← Back

iTonic Holdings Ltd.

iTonic Holdings Ltd. is a healthcare solutions provider that develops and commercializes treatment software and devices for brachytherapy. Its proprietary treatment planning system supports radioactive particle implantation, a radiotherapy that places radioactive sources inside the patient to kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for various malignant tumors that can determine target volume, prescription dose, and dose limits for protecting organs at risk, producing a safe, effective, and accurate dose distribution plan for brachytherapy. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. Founded in 1998, it is headquartered in Beijing, China, and operates as a subsidiary of ZJW (BVI) LTD.

Country
Price · split & dividend adjusted
News & notes moving ITOC
ITOC▼

Class Action Lawsuit Filed Against iTonic Holdings for Alleged Market Manipulation Scheme

A shareholder class action lawsuit has been filed against iTonic Holdings Ltd., formerly known as Pheton Holdings Ltd., alleging that the company made false or misleading statements and failed to disclose a market manipulation and fraudulent promotion scheme involving social-media misinformation and impersonators. The lawsuit claims that iTonic's public statements omitted any mention of fraudulent trading or the risk of market manipulation used to drive its stock price, leaving securities at unique risk of extreme volatility and trading halts. Investors who purchased iTonic shares between September 5, 2024 and July 29, 2025 and suffered losses are encouraged to contact Holzer & Holzer, LLC to discuss their legal rights. The deadline to seek appointment as lead plaintiff is September 29, 2026.
ITOC ▼PTHL ▼
GlobeNewswire·44dRead more →
ITOC▲

iTonic Holdings advances AI-powered cloud platform for nuclear medicine treatment planning

iTonic Holdings Ltd announced continued progress in developing its AI-enabled Treatment Planning System Cloud Platform through its 60%-owned subsidiary Mili Medical. The platform is being built to transform standalone treatment planning software into a browser-based, cloud collaboration tool integrating artificial intelligence, automated quality control, and healthcare data connectivity. Core cloud architecture, browser-based functionality, a medical data sharing framework, initial AI model training, and a quality control rule framework have been completed, with internal testing and clinical workflow validation now underway. The platform has not yet received regulatory approval or registration for commercial use, and the company is evaluating collaboration opportunities with healthcare institutions to support future deployment. iTonic Holdings aims to address digital transformation in precision medicine by enabling multi-location access, AI-assisted workflows for tasks like organ segmentation, and potential expansion into areas such as supply chain management and medical robotics integration.
ITOC ▲
GlobeNewswire·65dRead more →
© 2026 MarketDXAsset